跳至主要内容
临床试验/NCT01853605
NCT01853605终止不适用

NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study

Allergan1 个研究点 分布在 1 个国家目标入组 3,811 人开始时间: 2003年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
Allergan
入组人数
3,811
试验地点
1
主要终点
Subject Satisfaction With Breast Implants on a 5-Point Scale

研究概览

简要总结

Post-approval study of the safety and effectiveness of NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants (Styles 410 FM, FF, MM, or MF) for breast augmentation, reconstruction, or revision

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •For entry in this study, subjects must have been enrolled in the 410 CA Clinical Study or 410 CARE Clinical Study under the inclusion criteria listed below and received NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants Styles 410 FM, FF, MM, or MF in 1 (for unilateral breast reconstruction or revision) or both breasts.
  • •Female, age 18 or older
  • •Present with one or more of the following conditions:
  • •Primary breast augmentation (i.e., no previous breast implant surgery) indicated for subject dissatisfaction, with size or shape of breast (e.g., mammary hypoplasia), asymmetry, ptosis, or aplasia
  • •Primary breast reconstruction (i.e., no previous breast implant surgery other than implantation of tissue expanders or contralateral augmentation for asymmetry) indicated, in the affected breast, for mastectomy for cancer, prophylactic mastectomy, or breast trauma (resulting in mastectomy) and for the unaffected breast, contralateral asymmetry (may be performed on the date of the mastectomy or the date when permanent implants are placed in the reconstructed breast)
  • •Breast implant revision surgery (i.e., removal and replacement of breast implants) indicated for previous augmentation or reconstruction with silicone-filled or saline-filled breast implants
  • •Has adequate tissue available to cover implants
  • •Willing to undergo MRI at the specified follow-up visit for subjects at MRI designated sites and be eligible for MRI (e.g., no implanted metal or metal devices, no history of severe claustrophobia)

排除标准

  • •For entry in this study, subjects must have been enrolled in the 410 CA Clinical Study or 410 CARE Clinical Study and met the exclusion criteria listed below but not received any NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled 410 X- or L-Style Breast Implants
  • •Does not have advanced fibrocystic disease considered to be premalignant without accompanying subcutaneous mastectomy
  • •Does not have existing carcinoma of the breast, without mastectomy
  • •Does not have abscess or infection in the body at the time of enrollment
  • •Is not pregnant or nursing
  • •Does not have any disease, including uncontrolled diabetes (e.g., HbA1c > 8%), that is clinically known to impact wound healing ability
  • •Does not show tissue characteristics that are clinically incompatible with mammaplasty, such as tissue damage resulting from radiation, inadequate tissue, compromised vascularity, or ulceration
  • •Does not have or is under treatment for any condition that may constitute an unwarranted surgical risk (e.g., unstable cardiac or pulmonary problems)
  • •Does not show psychological characteristics that may be incompatible with the surgical procedure and the prosthesis, such as inappropriate attitude or motivation (e.g., body dysmorphic disorder)
  • •Is not willing to undergo further surgery for revision, if medically required

研究组 & 干预措施

Augmentation

Experimental

Women undergoing breast augmentation.

干预措施: Anatomically shaped silicone gel-filled breast implants (Device)

Reconstruction

Experimental

Women undergoing breast reconstruction.

干预措施: Anatomically shaped silicone gel-filled breast implants (Device)

Revision-Augmentation

Experimental

Women undergoing revision of previous breast augmentation.

干预措施: Anatomically shaped silicone gel-filled breast implants (Device)

Revision-Reconstruction

Experimental

Women undergoing revision of previous breast reconstruction.

干预措施: Anatomically shaped silicone gel-filled breast implants (Device)

结局指标

主要结局

Subject Satisfaction With Breast Implants on a 5-Point Scale

时间窗: 5 years

Subject satisfaction with each breast implant is assessed on the following 5-point scale: (Definitely Satisfied, Somewhat Satisfied, Neither Satisfied nor Dissatisfied, Somewhat Dissatisfied, and Definitely Dissatisfied). Satisfaction is reported for subject's assessing satisfaction as definitely satisfied and somewhat satisfied. The worst response is used if the subject reports different responses for the left and right breasts.

Investigator Satisfaction With Breast Implants on a 5-Point Scale

时间窗: 5 years

Investigator satisfaction with each breast implant is assessed on the following 5-point scale: (Definitely Satisfied, Somewhat Satisfied, Neither Satisfied nor Dissatisfied, Somewhat Dissatisfied, and Definitely Dissatisfied). Satisfaction is reported for Investigator's assessing satisfaction as definitely satisfied and somewhat satisfied. The worst response is used if the Investigator reports different responses for the left and right breasts.

Local Complications

时间窗: 5 years

Local complications are the cumulative complications occurring in at least 5% of subjects in 1 or more cohorts over the duration of the study. The Kaplan-Meier risk rate is presented.

次要结局

未报告次要终点

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验